This is a summary of a story originally on Duke University School of Nursing. Sickle cell disease occurs with the production of abnormally shaped red blood cells that resemble a sickle. These cells ...
Add Yahoo as a preferred source to see more of our stories on Google. A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston, Massachusetts, U.S., October 23, 2019.
TDT is a serious, life-threatening genetic disease. TDT patients report health-related quality of life scores below the general population and significant health care resource utilization. TDT ...
Two gene therapies were approved by the U.S. Food and Drug Administration in December 2023 for the treatment of sickle cell disease, an inherited disorder that affects the shape of red blood cells.
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) on Saturday presented data from multiple studies demonstrating the clinical benefits of Casgevy (exagamglogene autotemcel) in patients aged 5 years ...
Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced the publication of data from the ongoing Phase 1/2 BEACON ...
Approximately 100,000 Americans are affected by Sickle Cell Disease, the most common form of an inherited blood disorder. As September came to a close, and with that, Sickle Cell Awareness Month, it’s ...
Red blood cells transport oxygen throughout your body, including to vital organs and tissues. They also help your body get rid of carbon dioxide. Too little or too many red blood cells may be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results